The selective muscarinic agonist is now in mid-stage development for movement disorders like Parkinson’s disease and dystonia.

Waiv, a Paris-based company catalyzing AI precision testing, today announced a $33 million financing round to accelerate the ...

Prostate cancer remains one of the most prevalent malignancies among men worldwide and achieving an accurate and timely diagnosis is essential for guiding appropriate treatment decisions and improving ...

Psychiatric diagnosis still relies on symptom checklists that were never designed to reflect biology. A peer-reviewed invited review published in Brain Medicine now synthesizes recent advances across ...

Researchers have made DNA storage rewritable, overcoming one of its biggest limitations. The breakthrough could turn DNA into a practical alternative to today’s energy-hungry data centers.

Mitochondria are the powerhouses of the cell and also a key factor in unraveling life processes and disease mechanisms. As a ...

Halia Therapeutics, a clinical-stage biopharmaceutical company advancing therapies grounded in human biology, today announced that it will deliver a company presentation at the BIO Investment & Growth ...

Abstract: Artificial neural networks thrive in solving the classification problem for a particular rigid task, acquiring knowledge through generalized learning behaviour from a distinct training phase ...

New identity reflects Company's evolution into an innovative data driven biotech company leveraging MITOLINE and mitochondrial carrier biology across oncology and inflammatory metabolic diseases Neve ...

Monitor your average blood sugar over a three-month period via an A1c test. The results shown on an A1c chart indicate normal blood sugar under 5.7%; higher numbers indicate prediabetes or diabetes.